Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4
Correlation of Single Nucleotide Polymorphism (SNP) Profile of Domain III of EGFR to Skin Toxicity and Disease Response to Treatment With Erbitux Requirements
Sponsor: Cancer Trials Ireland
Terminated
As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up.
Other terminated trials from Cancer Trials Ireland
Other Colorectal Cancer trials with similar outcome
A observational or N/A phase clinical study on Colorectal Cancer and Non-Small Cell Lung Cancer, this trial is terminated or withdrawn. The trial is conducted by Cancer Trials Ireland and has accumulated 12 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Aug 2025 — Present [monthly]
Terminated
-
Sep 2024 — Aug 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
May 2023 — Jul 2024 [monthly]
Terminated
-
Feb 2022 — May 2023 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
▶ Show 7 earlier versions
-
Jan 2021 — Feb 2022 [monthly]
Active Not Recruiting
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Aug 2019 — Mar 2020 [monthly]
Recruiting
-
Nov 2018 — Aug 2019 [monthly]
Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Trials Ireland
For direct contact, visit the study record on ClinicalTrials.gov .